相关实验视频

Updated: Jul 10, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

下一代测序测试的临床实用性和补偿,以检测髓状细胞恶性瘤

Craig R Soderquist1, Christopher Freeman1, Wen-Hsuan Lin1

  • 1Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.

The Journal of molecular diagnostics : JMD
|November 19, 2023
PubMed
概括

下一代测序 (NGS) 在诊断和管理髓状细胞癌症方面具有显著的临床价值. 然而,还原挑战仍然存在,由于付款人政策,许多测试被拒绝,突出了公用事业和覆盖范围之间的差距.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
89.0K